A Dose-escalation Study to Evaluate the Safety and Clinical Activity of PBCAR269A, With or Without Nirogacestat, in Study Participants With Relapsed/Refractory Multiple Myeloma
Clinical trial NCT04171843 · TERMINATED
Trial details
- NCT number
- NCT04171843
- Sponsor
- Precision BioSciences, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-30
- Primary completion
- 2022-10-19
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.